FDA broadens APDS treatment options - Poll - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA broadens APDS treatment options

An 8-patient study evaluated safety and pharmacokinetics in the younger pediatric population.

  • By

  • Kathryn Wighton

  • September 14, 2026

  • 3 min

Share

Original Source(s)

FDA broadens APDS treatment options

  • by Kathryn Wighton

  • September 14, 2026

Related Content

Rare Disease AI Puts Variants in Focus

aiDIVA combines genomic evidence, phenotype matching, machine learning, and language models

  • September 24, 2026

  • 3 min
Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

Parents’ Perspectives on Using Computerized Cognitive Training to Manage Cognitive Late Effects in Children With Cancer: Qualitative Descriptive Study